NuProbe
Latest round
- Series A
Last raised
- Apr 2018
Total raised
- $11M
Investors
- 3
About NuProbe
NuProbe, Inc., founded in 2016, is based in Houston, US. The company specializes in genomic technologies and was formed following a merger with Carrier Gene in January 2020. The founders include Chai Yingshuang, David Zhang, Junfeng Luo, and Peng Yin, with Chai Yingshuang serving as CEO.NuProbe develops advanced genomic technologies that improve the sensitivity of analytical assays for DNA biomarkers, particularly in oncology.01%, and the QASeq platform for ultrahigh-sensitivity detection of copy number variations and mutations from FFPE tissue and cfDNA.NuProbe operates on a B2B model, primarily serving research institutions and laboratories. The company generates revenue through partnerships and licensing agreements, including an exclusive arrangement with Bio-Rad for digital PCR applications. Institutions purchase assay kits and services tailored to their research needs, with flagship products like the VarTrace series and QASeq technology.NuProbe plans to expand its product offerings and geographic presence. The company is focused on developing new products aimed at enhancing genomic research capabilities, although specific product release dates were not mentioned.
Who invested in NuProbe
3 investors across 1 round
See all investors in NuProbe
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 23, 2018
Amount
$11M
Investors
Questions about NuProbe
Who invested in NuProbe?
NuProbe has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NuProbe raised?
NuProbe has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did NuProbe last raise money?
NuProbe's most recent round on record is a Series A, in Apr 2018.
What does NuProbe do?
NuProbe is a biotechnology company.
Where is NuProbe headquartered?
NuProbe is headquartered in Houston, US.
Which VCs invest in companies like NuProbe?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at NuProbe's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like NuProbe? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.